Biotimize

Biotimize is the first Contract Development and Manufacturing Organization (CDMO) for biologics in operation in Brazil. Our mission is to democratize access to biotechnology by accelerating the development and production of high-quality biopharmaceuticals — making transformative treatments more accessible, both in Brazil and globally. Founded and based in Piracicaba, São Paulo, Biotimize provides end-to-end solutions for the development of biologics, from cell line development and process optimization to the production of non-clinical material. We serve as a strategic partner for biotechnology companies, research institutes, and public health initiatives seeking to bring innovation to market faster and more cost-effectively. Our approach combines scientific excellence, cutting-edge technology, and a deep understanding of regulatory standards. We are the only CDMO in Brazil offering Beacon platform services for cell line development, which drastically improves clone selection speed and precision. We're also supported by non-dilutive public funding from institutions like FINEP and BNDES, which strengthens our capacity for innovation. Biotimize is currently expanding. We're building Brazil’s first GMP-ready manufacturing plant focused exclusively on biologics, aimed at clinical and commercial supply. This new facility will position us as a key player in strengthening Brazil’s biopharma ecosystem and fostering health sovereignty in Latin America. Whether you're developing monoclonal antibodies, biosimilars, vaccines, or other biologics — Biotimize is your bridge between scientific discovery and real-world impact. Let’s make innovation accessible. Together.